Deutsche Bank Ag\ Ab Cellera Biologics Inc. Transaction History

Deutsche Bank Ag\

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $619,419 - $830,634	-109,438 Reduced 36.06%	194,032 $1.25 Million
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $620,253 - $948,623	84,850 Added 38.81%	303,470 $2.29 Million
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $236,848 - $362,767	24,984 Added 12.9%	218,620 $2.21 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $36,064 - $53,625	3,920 Added 2.07%	193,636 $1.92 Million
Q2 2022 Aug 11, 2022	BUY	$5.72 - $10.65 $455,369 - $847,846	79,610 Added 72.3%	189,716 $2.02 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $821,390 - $1.56 Million	110,106 New	110,106 $1.07 Million
Q4 2021 Feb 11, 2022	SELL	$12.99 - $17.73 $89,475 - $122,124	-6,888 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$14.85 - $21.34 $102,286 - $146,989	6,888 New	6,888 $138,000
Q2 2021 Aug 11, 2021	SELL	$20.19 - $34.17 $48,355 - $81,837	-2,395 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$23.29 - $53.2 $55,779 - $127,414	2,395 New	2,395 $81,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.